IFN-β Acts on Monocytes to Ameliorate CNS Autoimmunity by Inhibiting Proinflammatory Cross-Talk Between Monocytes and Th Cells.
Publication/Presentation Date
1-1-2021
Abstract
IFN-β has been the treatment for multiple sclerosis (MS) for almost three decades, but understanding the mechanisms underlying its beneficial effects remains incomplete. We have shown that MS patients have increased numbers of GM-CSF
Volume
12
First Page
679498
Last Page
679498
ISSN
1664-3224
Published In/Presented At
Rasouli, J., Casella, G., Ishikawa, L. L. W., Thome, R., Boehm, A., Ertel, A., Melo-Silva, C. R., Mari, E. R., Porazzi, P., Zhang, W., Xiao, D., Sigal, L. J., Fortina, P., Zhang, G. X., Rostami, A., & Ciric, B. (2021). IFN-β Acts on Monocytes to Ameliorate CNS Autoimmunity by Inhibiting Proinflammatory Cross-Talk Between Monocytes and Th Cells. Frontiers in immunology, 12, 679498. https://doi.org/10.3389/fimmu.2021.679498
Disciplines
Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods
PubMedID
34149716
Department(s)
Administration and Leadership
Document Type
Article